Gyre Therapeutics (GYRE) Research & Development (2010 - 2026)
Gyre Therapeutics' Research & Development came in at $19.14 million for Q2 2026, up 129.1% from $8.35 million a year earlier and up 184.0% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gyre Therapeutics reported Research & Development of $33.05 million, up 84.3% year-over-year; for FY2025, it was $13.7 million, up 13.9% from FY2024.
- Research & Development carries a five-year compound annual growth rate of -23.7% (FY2020 to FY2025).
- Going back by year, Research & Development was $12.02 million in FY2024 (-12.7%), $13.78 million in FY2023 (-17.4%), $16.69 million in FY2022 (-75.8%) and $68.89 million in FY2021 (+30.0%).
- The Q2 2026 figure represents the highest quarterly Research & Development since Q3 2021.
- Year-over-year, Research & Development has increased for three consecutive quarters, with growth averaging 53.2% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2023 (growth of 274.7%), and the weakest in Q3 2022 (a decline of 96.1%).
- Business Quant data shows GYRE's Research & Development at $6.74 million (Q1 2026), $4.82 million (Q4 2025) and $2.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Gyre Therapeutics | 592.25 Mn | 360.40 Mn | 26.90 Mn | 19.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.14 Mn |
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 8.35 Mn |
| Mar 31, 2025 | 3.10 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 2.78 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 4.57 Mn |
| Sep 30, 2023 | 3.01 Mn |
| Jun 30, 2023 | 3.57 Mn |
| Mar 31, 2023 | 2.64 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 803,000.00 |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 9.70 Mn |
| Dec 31, 2021 | 16.14 Mn |
| Sep 30, 2021 | 20.35 Mn |
API Access
Gyre Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();